Paper24367641
ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.
Moelans CB and 4 others. PLoS One, 2013. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous. Papers, record 24367641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24367641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Estrogen Receptor alpha | Major topic |
| Gene Amplification | Major topic |
| In Situ Hybridization, Fluorescence | Major topic |
| Ribonucleases | Major topic |
| Artifacts | |
| DNA Copy Number Variations | |
| Humans | |
| Laser Capture Microdissection | |
| Tissue Array Analysis |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17070983 | Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients. | Eur Urol | 2007 | https://conductscience.org/library/papers/17070983 | PubMed |
| 2 | 14077492 | THE DESTABILIZING EFFECT OF RIBONUCLEASE ON THE HELICAL DNA STRUCTURE. | Proc Natl Acad Sci U S A | 1963 | https://conductscience.org/library/papers/14077492 | PubMed |
| 3 | 993211 | DNA "melting" proteins. I. Effects of bovine pancreatic ribonuclease binding on the conformation and stability of DNA. | J Biol Chem | 1976 | https://conductscience.org/library/papers/993211 | PubMed |
| 4 | 7585609 | ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer. | Cancer Res | 1995 | https://conductscience.org/library/papers/7585609 | PubMed |
| 5 | 8557734 | Nonrandom gene organization: structural arrangements of specific pre-mRNA transcription and splicing with SC-35 domains. | J Cell Biol | 1995 | https://conductscience.org/library/papers/8557734 | PubMed |
| 6 | 17417639 | Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. | Nat Genet | 2007 | https://conductscience.org/library/papers/17417639 | PubMed |
| 7 | 19052028 | An overview of the epidermal growth factor receptor fluorescence in situ hybridisation challenge in tumour pathology. | J Clin Pathol | 2009 | https://conductscience.org/library/papers/19052028 | PubMed |
| 8 | 16756668 | Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia. | BMC Genomics | 2006 | https://conductscience.org/library/papers/16756668 | PubMed |
| 9 | 16288303 | HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients. | Br J Cancer | 2005 | https://conductscience.org/library/papers/16288303 | PubMed |
| 10 | 12360235 | Human cytogenetics: 46 chromosomes, 46 years and counting. | Nat Rev Genet | 2002 | https://conductscience.org/library/papers/12360235 | PubMed |
| 11 | 20826716 | EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer. | Ann Oncol | 2011 | https://conductscience.org/library/papers/20826716 | PubMed |
| 12 | 18607067 | MLPAnalyzer: data analysis tool for reliable automated normalization of MLPA fragment data. | Cell Oncol | 2008 | https://conductscience.org/library/papers/18607067 | PubMed |
| 13 | 20442492 | Multiplex ligation-dependent probe amplification to detect HER2 amplification in breast cancer: new insights in optimal cut-off value. | Cell Oncol | 2010 | https://conductscience.org/library/papers/20442492 | PubMed |
| 14 | 22942022 | Statistical challenges associated with detecting copy number variations with next-generation sequencing. | Bioinformatics | 2012 | https://conductscience.org/library/papers/22942022 | PubMed |
| 15 | 21986093 | Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial. | Ann Oncol | 2012 | https://conductscience.org/library/papers/21986093 | PubMed |
| 16 | 16791841 | MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. | Hum Mutat | 2006 | https://conductscience.org/library/papers/16791841 | PubMed |
| 17 | 16051952 | Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/16051952 | PubMed |
| 18 | 8608736 | Reutilization of previously hybridized slides for fluorescence in situ hybridization. | Cytometry | 1995 | https://conductscience.org/library/papers/8608736 | PubMed |
| 19 | 19320640 | Estrogen receptor alpha gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients. | Cancer Sci | 2009 | https://conductscience.org/library/papers/19320640 | PubMed |
| 20 | 22137795 | Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. | Cancer Cell | 2011 | https://conductscience.org/library/papers/22137795 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40244377 | Molecular Mechanisms and Therapeutic Strategies to Overcome Resistance to Endocrine Therapy and CDK4/6 Inhibitors in Advanced ER+/HER2- Breast Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40244377 | PubMed |
| 38930141 | Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. | J Clin Med | 2024 | https://conductscience.org/library/papers/38930141 | PubMed |
| 35179206 | Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma. | Br J Surg | 2022 | https://conductscience.org/library/papers/35179206 | PubMed |
| 33229445 | Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination. | Gut | 2021 | https://conductscience.org/library/papers/33229445 | PubMed |
| 30995757 | Clinical and Biological Significance of ESR1 Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30995757 | PubMed |
| 30382472 | Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals. | Breast Cancer Res Treat | 2019 | https://conductscience.org/library/papers/30382472 | PubMed |
| 29736566 | The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer. | Horm Cancer | 2018 | https://conductscience.org/library/papers/29736566 | PubMed |
| 27761212 | Are Estrogen Receptor Genomic Aberrations Predictive of Hormone Therapy Response in Breast Cancer? | Iran J Cancer Prev | 2016 | https://conductscience.org/library/papers/27761212 | PubMed |
| 27160768 | Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth. | Sci Rep | 2016 | https://conductscience.org/library/papers/27160768 | PubMed |
| 27081639 | Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate. | World J Clin Oncol | 2016 | https://conductscience.org/library/papers/27081639 | PubMed |
| 25907219 | Mechanisms of aromatase inhibitor resistance. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/25907219 | PubMed |
| 25838462 | Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators. | J Natl Cancer Inst | 2015 | https://conductscience.org/library/papers/25838462 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| ERBB3 | 2065 | PubTator's text mining | https://conductscience.org/library/genes/2065 | NCBI Gene |
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| ESR2 | 2100 | PubTator's text mining | https://conductscience.org/library/genes/2100 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| PIK3CA | 5290 | PubTator's text mining | https://conductscience.org/library/genes/5290 | NCBI Gene |
| RNASE1 | 6035 | PubTator's text mining | https://conductscience.org/library/genes/6035 | NCBI Gene |
| SOD2 | 6648 | PubTator's text mining | https://conductscience.org/library/genes/6648 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24367641
GET https://conductscience.org/api/papers/v1/24367641/references?page=2